Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Circular Industries Holding Pte. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is being handled within 1 distinct art unit, reflecting a highly concentrated prosecution focus. The involvement of 1 distinct examiner indicates that the current patent office interaction is localized to a specific technical review path.
LOUNTOS, GEORGE THEMISTOCLIS serves as the busiest examiner for the portfolio, with 1 pending office action under their review. Since there is only 1 pending office action in total, this examiner is responsible for the entirety of the company's active prosecution workload. This concentration in 1 distinct art unit suggests that the underlying technology is specialized within a specific niche of the Biotechnology & Pharmaceuticals field.
For a practitioner, the presence of 1 distinct examiner means that the outcome of the current prosecution cycle depends entirely on the feedback from a single individual. The alignment of the 1 pending office action with the busiest examiner simplifies the tracking of procedural deadlines. This focused data point highlights a streamlined entry into the patent system for the company's current technological interests.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LOUNTOS, GEORGE THEMISTOCLIS | 1 | 57.1% | +60.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18557456 | RECOMBINANT YEASTS FOR PRODUCING ACETONE AND/OR ISOPROPANOL FROM FATTY ACID FEEDSTOCKS | LOUNTOS, GEORGE THEMISTOCLIS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18557456 | RECOMBINANT YEASTS FOR PRODUCING ACETONE AND/OR ISOPROPANOL FROM FATTY ACID FEEDSTOCKS | LOUNTOS, GEORGE THEMISTOCLIS | — |
| Art Unit | Apps |
|---|---|
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18557456 | RECOMBINANT YEASTS FOR PRODUCING ACETONE AND/OR ISOPROPANOL FROM FATTY ACID FEEDSTOCKS | LOUNTOS, GEORGE THEMISTOCLIS | 1699 | §102§103§112 | Non-Final OA | — | Pending | Oct 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCircular Industries Holding Pte. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
George Themistoclis Lountos has the most, with 1 of Circular Industries Holding Pte. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
